CVS pharmacy and convenience store, building exterior, New York City, New York, USA. (Photo by: GHI-Plexi Images/UCG/Universal Images Group via Getty Images) Given the current uncertain macroeconomic ...

CVS Health plans to become a big player in primary care. During CVS Health’s Q2 earnings call on Wednesday, CEO Karen Lynch indicated that the company wants to team up with a provider that has a ...

Growth across all segments drove strong fourth-quarter and full-year results for CVS Health. For the three months and year compared to the prior year, total revenues for the retailer increased by 9.5% ...

CVS Health (NYSE: CVS) is scheduled to report its Q2 2022 results on Wednesday, August 3. We expect CVS stock to trade higher post the results announcement, with Q2 revenue and earnings likely being ...

Ladies and gentlemen, good morning and welcome to the CVS Health Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] As a reminder, today’s conference is being recorded ...

CVS Health Corp. said its revenue for all of fiscal 2022 exceeded its guidance that topped out at $314 billion. Adjusted earnings per share for the year were close to the top end of its guidance of $8 ...

CVS Health's valuation and stability have attracted investors amid the current market volatility. The company's Q2 results underscored its underlying business strength. CVS Health won't appeal to ...

Ladies and gentlemen, good morning, and welcome to the CVS Health Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session ...

CVS Health on Wednesday lifted its earnings outlook for the year, after beating Wall Street's expectations for the fiscal second quarter. The health-care company said it now expects adjusted earnings ...

CVS Health stock (NYSE: CVS) currently trades at $58 per share, 47% below its pre-inflation shock high of $110 seen in February 2022. In contrast, its peer – Walgreens stock (NASDAQ:WBA) – is down 75% ...